Peter Mueller, EVP, Global R&D, CSO at VERTEX PHARMACEUTICALS INC / MA (VRTX), sold 7,500 shares at $86.66 ($648K) on 2013-07-15, disclosed to the SEC on 2013-07-17.
Scheduled sale ($648k) by EVP, Global R&D, CSO under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $86.17 | 4,965 | $428K | 66.1% |
| 2 | $86.66 | 2,535 | $220K | 33.9% |
| Total | $86.34 avg | 7,500 | $648K | 100% |
| Filing → |
| BTAI | BUY | 2018-12-07 | $44K | — | Filing → |
| BTAI | BUY | 2018-12-06 | $21K | — | Filing → |
| VRTX | SELL | 2014-06-18 | $512K | — | Filing → |